2018
DOI: 10.1186/s12860-018-0170-3
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Trypanosoma cruzi with 2-bromopalmitate alters morphology, endocytosis, differentiation and infectivity

Abstract: BackgroundThe palmitate analogue 2-bromopalmitate (2-BP) is a non-selective membrane tethered cysteine alkylator of many membrane-associated enzymes that in the last years emerged as a general inhibitor of protein S-palmitoylation. Palmitoylation is a post-translational protein modification that adds palmitic acid to a cysteine residue through a thioester linkage, promoting membrane localization, protein stability, regulation of enzymatic activity, and the epigenetic regulation of gene expression. Little is kn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 56 publications
0
4
0
1
Order By: Relevance
“…The phenotypic effect of crosstalk was further studied by measuring P. falciparum growth inhibition against individual and combinatorial treatments with ST092793 and 2-BMP which are generic inhibitors of phosphorylation and palmitoylation, respectively. Although 2-BMP is known to have non-specific effects ( DeJesus and Bizzozero, 2002 ; Zheng et al., 2015 ), it has been used extensively to target palmitoylation-based pathways in L. donovani , T. cruzi , and Toxoplasma ( Foe et al., 2015 ; Ayana et al., 2018 ; Batista et al., 2018b ; Batista et al., 2018a ) for reducing infectivity. Plausibly, one of our recent unpublished data has also shown that 2-BMP has no impact on overall morphology of host RBCs.…”
Section: Discussionmentioning
confidence: 99%
“…The phenotypic effect of crosstalk was further studied by measuring P. falciparum growth inhibition against individual and combinatorial treatments with ST092793 and 2-BMP which are generic inhibitors of phosphorylation and palmitoylation, respectively. Although 2-BMP is known to have non-specific effects ( DeJesus and Bizzozero, 2002 ; Zheng et al., 2015 ), it has been used extensively to target palmitoylation-based pathways in L. donovani , T. cruzi , and Toxoplasma ( Foe et al., 2015 ; Ayana et al., 2018 ; Batista et al., 2018b ; Batista et al., 2018a ) for reducing infectivity. Plausibly, one of our recent unpublished data has also shown that 2-BMP has no impact on overall morphology of host RBCs.…”
Section: Discussionmentioning
confidence: 99%
“…A similar titrated inhibitor-based approach as described above was followed to inhibit fatty acid oxidation in fresh and desiccated Aedes eggs, and 0.8 mM of 2-bromopalmitic acid (Sigma Aldrich, 238422) was added to fresh blood used for feeding 10 days old female mosquitoes. This concentration was specifically chosen based on our optimised range for DFMO treatment which served as a reference and from published data by [ 77 ]. Higher doses of the drug (>1.2 mM) led to the mortality of adult females.…”
Section: Methodsmentioning
confidence: 99%
“…Vero cells (CCL-81) isolated from the kidney of the African green monkey Cercopithecus aethiops [ 17 ] were purchased from ATCC® (Washington DC, USA). The cells were inoculated in 200 μL of Dulbecco’s modified Eagle (DMEM) medium in 96-well plates at a concentration of 2 × 10 4 cells/well and incubated at 37°C for 24 h for adherence of the cells [ 18 ]. Six different concentrations of the compounds (12 to 900 μM for butanolides, and 200 to 1,600 μM for benznidazole) were added to the wells.…”
Section: Methodsmentioning
confidence: 99%